Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Procalcitonin: Nice to Know, Need to know, or Needs Further Research?

  • Conference paper
Intensive Care Medicine

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 2007))

  • 970 Accesses

Abstract

Sepsis remains a major cause of death in critically ill patients admitted to the intensive care unit (ICU) [1–2]. Infections increase the all-cause mortality during ICU admission from 12.1% in non-infected patients to 43.9% in infected patients [3]. Timely and effective antimicrobial treatment has crucial importance for prognosis. Delayed correct antimicrobial treatment substantially increases mortality [4]. The Surviving Sepsis Campaign has optimized multifactorial sepsis treatment in an evidence-based manner, to the benefit of critically ill patients with sepsis [5].

on behalf of the Procalcitonin and Survival Study (PASS) Group (see Appendix)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 3:2742–2751

    Article  Google Scholar 

  2. Alberti C, Brun-Buisson C, Burchardi H, et al (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121

    Article  PubMed  Google Scholar 

  3. Alberti C, Brun-Buisson C, Goodman SV, et al (2003) European Sepsis Group. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84

    Article  PubMed  Google Scholar 

  4. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474

    Article  CAS  PubMed  Google Scholar 

  5. Dellinger RP, Carlet JM, Masur H, et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873

    Article  PubMed  Google Scholar 

  6. Weglohner W, Struck J, Fischer-Schulz C, et al (2001) Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 22:2099–2103

    Article  CAS  PubMed  Google Scholar 

  7. Birnbaum RS, Mahoney WC, Burns DM, O’Neil JA, Miller RE, Roos BA (1984) Identification of procalcitonin in a rat medullary thyroid carcinoma cell line. J Biol Chem 259:2870–2874

    CAS  PubMed  Google Scholar 

  8. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr (2004) Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512–1525

    Article  CAS  PubMed  Google Scholar 

  9. Chesney RW, McCarron DM, Haddad JG, et al (1983) Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 101:576–585

    CAS  PubMed  Google Scholar 

  10. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396–404

    Article  CAS  PubMed  Google Scholar 

  11. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B (2005) Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9:R816–824

    Article  PubMed  Google Scholar 

  12. Burns DM, Forstrom JM, Friday KE, Howard GA, Roos BA (1989) Procalcitonin’s amino-terminal cleavage peptide is a bone-cell mitogen. Proc Natl Acad Sci USA 86:9519–9523

    Article  CAS  PubMed  Google Scholar 

  13. Monneret G, Arpin M, Venet F, et al (2003) Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med 29:923–928

    PubMed  Google Scholar 

  14. Wiedermann FJ, Kaneider N, Egger P, et al (2002) Migration of human monocytes in response to procalcitonin. Crit Care Med 30:1112–1117

    Article  CAS  PubMed  Google Scholar 

  15. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W (2002) Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 30:2091–2095

    Article  CAS  PubMed  Google Scholar 

  16. Whang KT, Vath SD, Becker KL, et al (2000) Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 14:73–78

    Article  CAS  PubMed  Google Scholar 

  17. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001–1006

    Article  CAS  PubMed  Google Scholar 

  18. Wagner KE, Martinez JM, Vath SD, et al (2002) Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 30:2313–2321

    Article  CAS  PubMed  Google Scholar 

  19. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596–2602

    Article  CAS  PubMed  Google Scholar 

  20. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87

    CAS  PubMed  Google Scholar 

  21. Level C, Chauveau P, Delmas Y, et al (2001) Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 16:980–986

    Article  CAS  PubMed  Google Scholar 

  22. Sitter T, Schmidt M, Schneider S, Schiffl H (2002) Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 15:297–301

    CAS  PubMed  Google Scholar 

  23. Level C, Chauveau P, Guisset O, et al (2003) Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 7:R160–166

    Article  PubMed  Google Scholar 

  24. Lindberg M, Hole A, Johnsen H, et al (2002) Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest 62:189–194

    Article  CAS  PubMed  Google Scholar 

  25. Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260–265

    Article  CAS  PubMed  Google Scholar 

  26. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684

    Article  CAS  PubMed  Google Scholar 

  27. Redl H, Schlag G, Togel E, Assicot M, Bohuon C (2000) Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin. Crit Care Med 28:3659–3663

    Article  CAS  PubMed  Google Scholar 

  28. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607

    Article  CAS  PubMed  Google Scholar 

  29. Christ-Crain M, Stolz D, Bingisser R? et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 174:84–93

    Article  CAS  PubMed  Google Scholar 

  30. Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481–1483

    Article  CAS  PubMed  Google Scholar 

  31. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and Creactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217

    Article  CAS  PubMed  Google Scholar 

  32. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D (1970) Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 283:447–451

    Article  CAS  PubMed  Google Scholar 

  33. Spackman TN (1994) A theoretical evaluation of cost-effectiveness of pulmonary artery catheters in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth 8:570–576

    Article  CAS  PubMed  Google Scholar 

  34. Connors AF Jr, Speroff T, Dawson NV, et al (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276:889–897

    Article  PubMed  Google Scholar 

  35. Wheeler AP, Bernard GR, Thompson BT, et al (2006) Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354:2213–2224

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Microbiology 445, University Hospital, Kettegard Allé 30, 2650, Hvidovre, Denmark

    J. -U. Jensen

  2. Department of Intensive Care 542, University Hospital, Kettegard Allé 30, 2650, Hvidovre, Denmark

    J. Løken

  3. Department of Intensive Care Y13, University Hospital, 2600, Glostrup, Denmark

    T. Mohr

Authors
  1. J. -U. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Løken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Mohr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science + Business Media Inc.

About this paper

Cite this paper

Jensen, J.U., Løken, J., Mohr, T. (2007). Procalcitonin: Nice to Know, Need to know, or Needs Further Research?. In: Intensive Care Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2007. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49433-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-49433-1_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-49432-4

  • Online ISBN: 978-3-540-49433-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation